Access to anti-retroviral drugs, female in Afghanistan
Afghanistan: Access to anti-retroviral drugs, female was 38.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Afghanistan, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, female in Afghanistan is 38.0%, measured in 2024. That is the highest value across all 25 years on record.
The figure is up 8.6% on the previous year and up 192.3% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Afghanistan peaked at 38.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places Afghanistan 129th out of 141 countries with data for 2024, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Afghanistan, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 0.0% | — |
| 2007 | 0.0% | — |
| 2008 | 0.0% | — |
| 2009 | 1.0% | — |
| 2010 | 3.0% | +200.0% |
| 2011 | 6.0% | +100.0% |
| 2012 | 7.0% | +16.7% |
| 2013 | 10.0% | +42.9% |
| 2014 | 13.0% | +30.0% |
| 2015 | 16.0% | +23.1% |
| 2016 | 30.0% | +87.5% |
| 2017 | 30.0% | +0.0% |
| 2018 | 29.0% | -3.3% |
| 2019 | 32.0% | +10.3% |
| 2020 | 32.0% | +0.0% |
| 2021 | 32.0% | +0.0% |
| 2022 | 32.0% | +0.0% |
| 2023 | 35.0% | +9.4% |
| 2024 | 38.0% | +8.6% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.1% | 0.0% | 1.0% | 10 |
| 2010s | 17.6% | 3.0% | 32.0% | 10 |
| 2020s | 33.8% | 32.0% | 38.0% | 5 |
Countries ranked near Afghanistan
More gender data for Afghanistan
- Child population (UN estimates and projections) 20,358 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 1.64 % change on previous year (2030)
- Population 29,681 (2030)
- Working-age population (UN estimates and projections) 29,681 (2030)
- Population (UN estimates and projections), annual growth rate 3.43 % change on previous year (2030)
- Age population, age 00, female, interpolated 707,563 (2025)
- Age population, age 00, male, interpolated 739,025 (2025)
- Age population, age 01, female, interpolated 690,872 (2025)
- Age population, age 01, male, interpolated 720,642 (2025)
- Age population, age 02, female, interpolated 674,248 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Afghanistan?
- Access to anti-retroviral drugs, female in Afghanistan was 38.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Afghanistan?
- The highest recorded value was 38.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Afghanistan?
- The lowest recorded value was 0.0% in 2000.
- How does Afghanistan rank for access to anti-retroviral drugs, female?
- Afghanistan ranks 129th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Afghanistan?
- Over the last ten years it is up 192.3%. The long-run trend across the full record is volatile.
- Where does this Afghanistan data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.